Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2023–2026 · award
Synergistically Disrupting Proteostasis in Acute Myeloid Leukemia Stem Cells
2023–2027 · award
Targeting innate immune cells to boost immune responses to melanoma
2023–2026 · award
Bone marrow vascular microenvironment combination RNAi-bortezomib nanotherapy for multiple myeloma
Michael Mitchell · The Trustees Of The University Of Pennsylvania
2023–2025 · award
Regulation of the Tumor Immune Cell Landscape by Ciliated Glioblastoma Cells
2023–2025 · award
Institutional Research Grant
2023–2025 · award
Institutional Research Grant
2023–2025 · award
Developing PROMIS: The blueprint of human proteome-metabolome interactions in cancers
2023–2026 · award
Cancer-Mesothelial Signaling that Promotes Ovarian Cancer Metastasis
2023–2025 · award
Examining Arginine and Urea Cycle Metabolism in Hepatocellular Carcinoma
2023–2026 · award
Assessing the Utility of Circulating miRNAs to Aid in the Management of Patients with Germ Cell Tumors
2023–2024 · award
Dissecting the impact of lung tumorigenesis on systemic physiology
2023–2025 · award
Diversity in Cancer Research Post Baccalaureate Fellows Program at UAB
2023–2025 · award
Targeting Negative Regulators in Cellular Immunotherapies for Degradation
2023–2025 · award
Investigating the role of ecDNAs in cancer initiation and progression
2023–2024 · award
Defining the role of macropinocytosis in the tumor-immune microenvironment
Rebecca Lim · University of California, Irvine
2023–2026 · award
PD-1/PD-L1 Interaction Attenuates T Cell Receptor Binding Affinity
2023–2025 · award
Markey STRONG Post-baccalaureate Program
2023–2024 · award
Pyrimidine Pathway Modulation to Overcome Immunotherapy Resistance in Colorectal Cancer
2023–2027 · award
Transcription and translation as resistance drivers to BET inhibition
2023–2024 · award
Defining in vivo tamoxifen metabolism by host–microbe interactions
2023–2025 · award
Inhibition of NEK2 as a novel therapy for viral lymphomas
2023–2027 · award
Mapping the complete genetic architecture of ovarian cancer to improve disease prevention.
2023–2027 · award
The role of HER2 activating mutations in ER+ breast cancer metastasis
2023–2027 · award
Harmony & Health: A culturally adapted mind-body intervention to reduce sitting time and improve psychosocial wellbeing in Black adults
Scherezade Mama · The University of Texas MD Anderson Cancer Center
2023–2026 · award
Effects of Mandates Eliminating Cost-Sharing: Evidence from Anthem Claims
2023–2025 · award
UACC Diversity in Cancer Research Post-Baccalaureate Fellows Program
Joann Sweasy · Arizona Board Of Regents, University Of Arizona
2023–2027 · award
Functional evidence to improve Lynch Syndrome variant interpretation
2023–2026 · award
Defining how oncogenic condensates alter cell perception of resistance signals in EML4-ALK+ cancer.
2023–2026 · award
Analysis of testis-specific nuclear non-coding genes in regulating estrogen-dependent transcription and gene-expression in ER-positive breast cancer
Shrikanth Gadad · Texas Tech University Health Sciences Center
2023–2027 · award
Combining volumetric breast density and polygenic risk scores to improve breast cancer risk assessment for black and white women
2023–2027 · award
Decoding the Effects of Phosphosite-Proximal Mutations on Phosphotyrosine Signaling
2023–2026 · award
Transposable element RNA biomarkers for cancer liquid biopsies
2023–2027 · award
Genomic Determinants and Origin of Small Bowel Adenocarcinoma
2023–2024 · award
Harnessing Metabolic Dependencies to Develop Novel Therapeutic Modalities for Pancreatic Cancer
Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute
2023–2026 · award
Therapeutic Disruption of the MYC Blood Super-Enhancer Complex in Acute Myeloid Leukemia
2023–2024 · award
A pilot randomized trial of a patient-centered communication tool (UR-GOAL) for older patients with acute myeloid leukemia and oncologists
2023–2024 · award
EXPLORING THE ROLE OF SUCCINATE RECEPTOR 1 SIGNALING IN BREAST CANCER PROGRESSION
2023–2024 · award
Regulation of tumor cell co-operation and breast cancer metastasis by Nectin-4
2023–2026 · award
Competition for Arginine between HCC tumor and immune cells
2023–2026 · award